EDT Eli Lilly & Co. is ready to buy again, four months after closing its largest acquisition ever, the $6 billion-plus purchase of cancer drug maker ImClone Systems Inc. Lilly Chief Executive John Lechleiter told The Wall Street ...
Sourse: More Info
Tuesday, March 31, 2009
Report: Eli Lilly looks to make more deals
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment